Integra LifeSciences Holdings Corporation (IART) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

Earnings Reports

• Integra LifeSciences (IART) Q2 2026: EBITDA Margin Expands 160bps as Supply Reliability and Portfolio Execution Improve
  July 29, 2026
• Integra LifeSciences (IART) Q1 2026: Tissue Reconstruction Grows 6.4% as Commercial Focus Deepens
  May 05, 2026
• Integra LifeSciences (IART) Q4 2025: Tissue Tech Down 12.8% as Supply and Tariff Pressures Shape 2026 Trajectory
  February 26, 2026
• Integra LifeSciences (IART) Q3 2025: CSS Segment Grows 7.1% as Supply Chain Overhaul Gains Traction
  October 30, 2025
• Integra LifeSciences (IART) Q2 2025: $100M Shiphold Impact Refines Turnaround Timeline
  July 31, 2025
• Integra LifeSciences (IART) Q1 2025: Ship Holds Double to $70M, Intensifying Turnaround Demands
  July 06, 2025

Browse all companies